COVID-19
Showing NaN - NaN of 62
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022
COVID-19 Outcome Prediction Algorithm
Active, not recruiting
- COVID-19
- +4 more
- Blood and nasal swab sampling
-
Los Angeles, California
- +6 more
Jul 20, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)
Recruiting
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +4 more
-
Athens, Alabama
- +158 more
Jul 18, 2022
COVID-19 Trial in Worldwide (SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1, SARS-CoV-2 recombinant protein
Active, not recruiting
- COVID-19
- SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1
- +10 more
-
Birmingham, Alabama
- +71 more
Jul 11, 2022
Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)
Recruiting
- Lower Respiratory Tract Infection
- +3 more
- DAS181
- +3 more
-
Duarte, California
- +59 more
Jun 3, 2022
Lung Inflammation in Post-COVID-19 Recovery
Recruiting
- COVID-19
- Acute Respiratory Distress Syndrome
- LLLT Photobiomodulation
-
Berkeley, California
- +6 more
Feb 24, 2022
COVID-19 Trial in United States (Apixaban 2.5 MG, Apixaban 5MG, Aspirin)
Terminated
- COVID-19
- Apixaban 2.5 MG
- +3 more
-
Los Angeles, California
- +70 more
Feb 15, 2022
COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,
Completed
- COVID-19
- +3 more
- Hydroxychloroquine Sulfate
- Ascorbic Acid
-
Los Angeles, California
- +7 more
Dec 14, 2021
COVID-19 Trial in Los Angeles (Clazakizumab)
Completed
- COVID-19
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 30, 2021
Covid-19, Sars-CoV2 Trial in Los Angeles, Baltimore (Multiple Doses of Anti-SARS-CoV-2 convalescent plasma)
Terminated
- Covid-19
- Sars-CoV2
- Multiple Doses of Anti-SARS-CoV-2 convalescent plasma
-
Los Angeles, California
- +1 more
Nov 1, 2021
Covid-19 Trial in Los Angeles (Tested for SARS-CoV-2 (regardless of the result), Clinical diagnosis of COVID-19 by a health care
Completed
- Covid-19
- Tested for SARS-CoV-2 (regardless of the result)
- Clinical diagnosis of COVID-19 by a health care professional
-
Los Angeles, CaliforniaPregistry
Sep 27, 2021
SARS-CoV-2-specific Immunity in Individuals Who Have Recovered
Active, not recruiting
- SARS-CoV-2
- COVID-19
- Sample collection
-
Birmingham, Alabama
- +52 more
Sep 3, 2021